Both in Biotechnology
Estrella Immunopharma vs BioStem Technologies
Over the past year ESLA returned −32.8% and BSEM returned −73.3%; their daily moves had a correlation of 0.04.
ESLA −32.8% BSEM −73.3%Growth of $1, one year, split-adjusted
| Metric | ESLA | BSEM |
|---|---|---|
| Price | $0.4435 | $1.15 |
| Market cap | $19.3M | $21.5M |
| Today | +6.10% | 0.00% |
| 1 month | +3.4% | −53.4% |
| 6 months | −65.9% | — |
| Year to date | −71.6% | — |
| 1 year | −85.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $146.7K | — |
| Dividend yield | — | — |
| Volatility (60d) | 201.6% | — |
| Short % of float | 4.0% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).